Shuttle Pharmaceuticals

(NASDAQ) SHPH

Current Price$1.02

Market Cap$5.87M

Since IPO (2022)-100%

5 YearN/A

1 Year-86%

1 Month+58%

Shuttle Pharmaceuticals Financials at a Glance

Market Cap

$5.87M

Revenue (TTM)

$0.00

Net Income (TTM)

$11.72M

EPS (TTM)

$-13.23

P/E Ratio

-0.08

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$1.02

Volume

100

Open

$1.02

Price

$1.02

Volume

100

Open

$1.02

Previous Close

$1.05

Daily Range

$1.02 - $1.02

52-Week Range

$0.50 - $11.25

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$1.02

Volume

100

Open

$1.02

Previous Close

$1.05

Daily Range

$1.02 - $1.02

52-Week Range

$0.50 - $11.25

SHPH News

healthcare lab treatment research scientist

Why Shares of Shuttle Pharmaceuticals Jumped 160.4% This Week

James HalleySep 9, 2022

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Shuttle Pharmaceuticals

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Christopher Robert Cooper, MBA

Website

www.shuttlepharma.com

Headquarters

Gaithersburg, MD 20850, US

SHPH Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-791%

Return on Capital

-5%

Return on Assets

-1%

Earnings Yield

-12.50%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$5.87M

Shares Outstanding

5.59M

Volume

100

Avg. Volume

246.03K

Financials (TTM)

Gross Profit

$0.00

Operating Income

$11.92M

EBITDA

$11.36M

Operating Cash Flow

$9.48M

Capital Expenditure

$5.00

Free Cash Flow

$9.48M

Cash & ST Invst.

$334.00K

Total Debt

$232.15K

Shuttle Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$289.07K

-15995.2%

Gross Margin

0.00%

N/A

Market Cap

$5.87M

N/A

Market Cap/Employee

$652.32K

N/A

Employees

N/A

Net Income

$2.61M

-63.6%

EBITDA

$2.50M

-73.9%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$101.86K

-86.4%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$154.95K

-34.9%

Short Term Debt

$77.19K

-91.7%

Return on Assets

-1.12%

N/A

Return on Invested Capital

-4.75%

N/A

Free Cash Flow

$973.01K

+63.8%

Operating Cash Flow

$973.01K

+63.8%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

HSCSHeartSciences Inc.

HSCSHeartSciences Inc.$1.99-1.00%

RDHLRedHill Biopharma Ltd.

RDHLRedHill Biopharma Ltd.$1.02-1.31%

BBLGBone Biologics Corporation

BBLGBone Biologics Corporation$1.34-2.90%

UPCUniverse Pharmaceuticals Inc.

UPCUniverse Pharmaceuticals Inc.$3.10+1.64%

IMCCIM Cannabis Corp.

IMCCIM Cannabis Corp.$0.27-2.39%

MSPRMSP Recovery, Inc.

MSPRMSP Recovery, Inc.$0.05+24.19%

ISPCiSpecimen Inc.

ISPCiSpecimen Inc.$4.51-8.38%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NVDANvidia

NVDANvidia$212.31-0.02%

POETPoet Technologies

POETPoet Technologies$8.20+0.03%

NOKNokia

NOKNokia$10.96+0.02%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$12.26-0.00%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$60.79-0.03%

BBBYBeyond, Inc.

BBBYBeyond, Inc.$5.47+0.02%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.01+0.04%

Questions About SHPH

What is the current price of Shuttle Pharmaceuticals?

Shuttle Pharmaceuticals is trading at $1.02 per share.

What is the 52-week range for Shuttle Pharmaceuticals?

Over the past 52 weeks, Shuttle Pharmaceuticals has traded between $0.50 and $11.25.

How much debt does Shuttle Pharmaceuticals have?

As of the most recent reporting period, Shuttle Pharmaceuticals reported total debt of $232,147.

How much cash does Shuttle Pharmaceuticals have on hand?

Shuttle Pharmaceuticals reported $334,005 in cash and cash equivalents in its most recent financial results.

What is Shuttle Pharmaceuticals’s dividend yield?

Shuttle Pharmaceuticals does not currently have a dividend yield.

Shuttle Pharmaceuticals

Shuttle Pharmaceuticals Financials at a Glance

SHPH News

Why Shares of Shuttle Pharmaceuticals Jumped 160.4% This Week

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Shuttle Pharmaceuticals

SHPH Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Shuttle Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About SHPH

What is the current price of Shuttle Pharmaceuticals?

What is the 52-week range for Shuttle Pharmaceuticals?

How much debt does Shuttle Pharmaceuticals have?

How much cash does Shuttle Pharmaceuticals have on hand?

What is Shuttle Pharmaceuticals’s dividend yield?

Premium Investing Services